tetano
Editor, Senior Moderator
J Patient Cent Res Rev
. 2021 Apr 19;8(2):151-153.
doi: 10.17294/2330-0698.1841. eCollection Spring 2021.
Preprocedure COVID-19 Testing in Early Phase of Pandemic
Renuka Jain[SUP] 1 [/SUP], Bradley Kruger[SUP] 2 [/SUP], Robert Citronberg[SUP] 3 [/SUP], Stacie Kroboth[SUP] 4 [/SUP], Ana Cristina Perez Moreno[SUP] 4 [/SUP], Bijoy K Khandheria[SUP] 1 [/SUP]
Affiliations
Abstract
The COVID-19 pandemic led to a nationwide shutdown of elective medical procedures. Upon resumption of services, preprocedure nasopharyngeal swab testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was introduced for all patients requiring surgical or other aerosol-generating procedures. We investigated preprocedure COVID-19 testing in one of the largest U.S. health systems. Patients included in this retrospective, observational study were asymptomatic and scheduled for a procedure or surgery. All patients underwent a nasopharyngeal swab test for SARS-CoV-2 performed 24-72 hours prior to a planned procedure. Clinical demographics, type of procedure, test results, and subsequent procedure status were evaluated. Of 38,608 total patients, there were 277 COVID-19-positive patients (positivity rate: 0.72%). Of those 277, 244 (88%) had procedural delays or cancellations. Of the COVID-19-negative patients, 50 (0.13%) required later hospitalization for COVID-19. Median time from preprocedure negative test to admission was 46.3 ? 27.2 days. In the largest series published on preprocedure COVID-19 testing in the early phase of the pandemic, preprocedure COVID-19 positivity was low. Preprocedure COVID-19 testing had a significant impact on clinical management. Rate of COVID-19 cases requiring hospitalization in the months following the procedure was negligible, suggesting health system policies adequately protected patient safety.
Keywords: COVID-19; SARS-CoV-2 testing; clinical management; health care delivery; hospitalization; patient safety; procedure; surgery.
. 2021 Apr 19;8(2):151-153.
doi: 10.17294/2330-0698.1841. eCollection Spring 2021.
Preprocedure COVID-19 Testing in Early Phase of Pandemic
Renuka Jain[SUP] 1 [/SUP], Bradley Kruger[SUP] 2 [/SUP], Robert Citronberg[SUP] 3 [/SUP], Stacie Kroboth[SUP] 4 [/SUP], Ana Cristina Perez Moreno[SUP] 4 [/SUP], Bijoy K Khandheria[SUP] 1 [/SUP]
Affiliations
- PMID: 33898649
- PMCID: PMC8060038
- DOI: 10.17294/2330-0698.1841
Abstract
The COVID-19 pandemic led to a nationwide shutdown of elective medical procedures. Upon resumption of services, preprocedure nasopharyngeal swab testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was introduced for all patients requiring surgical or other aerosol-generating procedures. We investigated preprocedure COVID-19 testing in one of the largest U.S. health systems. Patients included in this retrospective, observational study were asymptomatic and scheduled for a procedure or surgery. All patients underwent a nasopharyngeal swab test for SARS-CoV-2 performed 24-72 hours prior to a planned procedure. Clinical demographics, type of procedure, test results, and subsequent procedure status were evaluated. Of 38,608 total patients, there were 277 COVID-19-positive patients (positivity rate: 0.72%). Of those 277, 244 (88%) had procedural delays or cancellations. Of the COVID-19-negative patients, 50 (0.13%) required later hospitalization for COVID-19. Median time from preprocedure negative test to admission was 46.3 ? 27.2 days. In the largest series published on preprocedure COVID-19 testing in the early phase of the pandemic, preprocedure COVID-19 positivity was low. Preprocedure COVID-19 testing had a significant impact on clinical management. Rate of COVID-19 cases requiring hospitalization in the months following the procedure was negligible, suggesting health system policies adequately protected patient safety.
Keywords: COVID-19; SARS-CoV-2 testing; clinical management; health care delivery; hospitalization; patient safety; procedure; surgery.